118 related articles for article (PubMed ID: 8543556)
21. Lack of correlation between ACAT mRNA expression and cholesterol esterification in primary liver cells.
Rea TJ; DeMattos RB; Homan R; Newton RS; Pape ME
Biochim Biophys Acta; 1996 Jan; 1299(1):67-74. PubMed ID: 8555254
[TBL] [Abstract][Full Text] [Related]
22. A selective inhibitor of intestinal ACAT, EAB309 suppresses both intestinal and hepatic cholesterol output and stimulates chylomicron removal.
Umeda Y; Hirano T; Kako Y; Kamagata K; Okuyama K; Suzuki K
Life Sci; 1998; 63(13):PL187-95. PubMed ID: 9763214
[TBL] [Abstract][Full Text] [Related]
23. ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys.
Carr TP; Hamilton RL; Rudel LL
J Lipid Res; 1995 Jan; 36(1):25-36. PubMed ID: 7706945
[TBL] [Abstract][Full Text] [Related]
24. Dual action of neutral sphingomyelinase on rat hepatocytes: activation of cholesteryl ester metabolism and biliary cholesterol secretion and inhibition of VLDL secretion.
Liza M; Chico Y; Fresnedo O; Ochoa B
Lipids; 2003 Jan; 38(1):53-63. PubMed ID: 12669820
[TBL] [Abstract][Full Text] [Related]
25. Cholesterol accumulation in J774 macrophages induced by triglyceride-rich lipoproteins. Comparison of very low density lipoprotein from subjects with type III, IV, and V hyperlipoproteinemias.
Huff MW; Evans AJ; Sawyez CG; Wolfe BM; Nestel PJ
Arterioscler Thromb; 1991; 11(2):221-33. PubMed ID: 1998641
[TBL] [Abstract][Full Text] [Related]
26. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
27. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge.
Cianflone KM; Yasruel Z; Rodriguez MA; Vas D; Sniderman AD
J Lipid Res; 1990 Nov; 31(11):2045-55. PubMed ID: 1964953
[TBL] [Abstract][Full Text] [Related]
28. Beta-VLDL in hepatic lipase deficiency induces apoE-mediated cholesterol ester accumulation in macrophages.
Huff MW; Sawyez CG; Connelly PW; Maguire GF; Little JA; Hegele RA
Arterioscler Thromb; 1993 Sep; 13(9):1282-90. PubMed ID: 8364012
[TBL] [Abstract][Full Text] [Related]
29. The role of factors that regulate the synthesis and secretion of very-low-density lipoprotein by hepatocytes.
Mason TM
Crit Rev Clin Lab Sci; 1998 Dec; 35(6):461-87. PubMed ID: 9885772
[TBL] [Abstract][Full Text] [Related]
30. In vivo evidence that the lipid-regulating activity of the ACAT inhibitor CI-976 in rats is due to inhibition of both intestinal and liver ACAT.
Krause BR; Anderson M; Bisgaier CL; Bocan T; Bousley R; DeHart P; Essenburg A; Hamelehle K; Homan R; Kieft K
J Lipid Res; 1993 Feb; 34(2):279-94. PubMed ID: 8429262
[TBL] [Abstract][Full Text] [Related]
31. Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester.
Wu X; Sakata N; Lui E; Ginsberg HN
J Biol Chem; 1994 Apr; 269(16):12375-82. PubMed ID: 8163541
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the role of lipids in the assembly of very low density lipoproteins in rabbit hepatocytes.
Cartwright IJ; Higgins JA; Wilkinson J; Bellavia S; Kendrick JS; Graham JM
J Lipid Res; 1997 Mar; 38(3):531-45. PubMed ID: 9101434
[TBL] [Abstract][Full Text] [Related]
33. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in cholesteryl ester storage disease.
Cummings MH; Watts GF
Clin Chem; 1995 Jan; 41(1):111-4. PubMed ID: 7813057
[TBL] [Abstract][Full Text] [Related]
34. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
Vaziri ND; Liang KH
Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
[TBL] [Abstract][Full Text] [Related]
35. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
Schuler LA; Toaff ME; Strauss JF
Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277
[TBL] [Abstract][Full Text] [Related]
36. ACAT2 stimulates cholesteryl ester secretion in apoB-containing lipoproteins.
Temel RE; Hou L; Rudel LL; Shelness GS
J Lipid Res; 2007 Jul; 48(7):1618-27. PubMed ID: 17438337
[TBL] [Abstract][Full Text] [Related]
37. Effects of F-1394, an acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on ACAT activity in HepG2 cells and on hepatic secretion of lipids in Triton WR-1339-induced hyperlipidemic rats: possible role of hepatic ACAT in very low density lipoprotein secretion.
Aragane K; Kusunoki J; Kitamine T; Yamaura T; Ohnishi H
Jpn J Pharmacol; 1998 Mar; 76(3):309-12. PubMed ID: 9593225
[TBL] [Abstract][Full Text] [Related]
38. Acyl-coenzyme A:cholesterol acyltransferase in human liver. In vitro detection and some characteristics of the enzyme.
Erickson SK; Cooper AD
Metabolism; 1980 Oct; 29(10):991-6. PubMed ID: 7421586
[TBL] [Abstract][Full Text] [Related]
39. Potential role of acyl-coenzyme A:cholesterol transferase (ACAT) Inhibitors as hypolipidemic and antiatherosclerosis drugs.
Leon C; Hill JS; Wasan KM
Pharm Res; 2005 Oct; 22(10):1578-88. PubMed ID: 16180116
[TBL] [Abstract][Full Text] [Related]
40. Effect of lovastatin on the secretion of very low density lipoprotein lipids and apolipoprotein B in the hypertriglyceridemic Zucker obese rat.
Kasim SE; Elovson J; Khilnani S; Almario RU; Jen KL
Atherosclerosis; 1993 Dec; 104(1-2):147-52. PubMed ID: 8141838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
